Ophiopogonin D
Cat. No. :YN360934
CAS No. :945619-74-9
86-020-82000279
sales@ubiochem.com
order@ubiochem.com| Product Name: | Ophiopogonin D |
| CAS NO.: | 945619-74-9 |
| Chemical Name: | |
| Synonyms: | |
| Molecular Weight: | 855.02 |
| Molecular Formula: | C₄₄H₇₀O₁₆ |
| SMILES: | C[C@@]12[C@]([C@@H]3C)([H])[C@](O[C@]34CC[C@@H](C)CO4)([H])C[C@@]1([H])[C@@](CC=C5[C@@]6([C@@H](C[C@H](O)C5)O[C@@](O[C@H](C)[C@H](O)[C@@H]7O[C@@](OC[C@@H](O)[C@@H]8O)([H])[C@@H]8O)([H])[C@@H]7O[C@@](O[C@@H](C)[C@H](O)[C@H]9O)([H])[C@@H]9O)C)([H])[C@]6([H])CC2 |
| Storage: | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Transportation: | Room temperature in continental US; may vary elsewhere. |
| Description: | Ophiopogonin D, isolated from the tubers ofOphiopogon japonicus, is a rare naturally occurring C29steroidal glycoside. Ophiopogonin D is a CYP2J3 inducer that significantly inhibits Ang II induced NF-κB nuclear translocation, IκBα down-regulation, intracellular Ca2+overload and activation of pro-inflammatory cytokines by increasing the expression ofCYP2J2/EETs and PPARαin human umbilical vein endothelial cells (HUVECs). Ophiopogonin D has been used to treat inflammatory and cardiovascular diseases for thous and s of years. |
| IC50&Target: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | |
| References: |
TELL : +86-020-82000279
Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.
